Search Results 251-260 of 17276 for Teratogenic

  1. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    ... teratogenic effects on the developing fetus and newborn are unknown: Pregnant women; Nursing women; Women of childbearing potential who are unwilling to ...

  2. VSV-hIFNbeta-NIS in Treating Patients With Stage IV or Recurrent Endometrial Cancer - Mayo Clinic

    Any of the following because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn ...

  3. STI-3031 Through Sofusa DoseConnect for Treatment of Intransit Melanoma - Mayo Clinic

    Any of the following because this study involves an investigational agent whose genotoxic, mutagenic, and teratogenic effects on the developing fetus and ...

  4. Apixaban in Preventing Secondary Cancer Related Blood Clots in Cancer Patients Who Have Completed Anticoagulation Therapy - Mayo Clinic

    ... teratogenic effects on the developing fetus and newborn are unknown: Pregnant women; Nursing women; Men or women of childbearing potential who are unwilling ...

  5. Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer - Mayo Clinic

    Any of the following because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn ...

  6. A Study to Evaluate Binimetinib in Combination with Encorafenib in Patients with Pancreatic Malignancies and a Somatic BRAFV600E Mutation - Mayo Clinic

    Any of the following because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn ...

  7. A Study to Evaluate Daratumumab in Treating Transplant-Eligible Participants with Multiple Myeloma - Mayo Clinic

    Any of the following because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn ...

  8. A Study to Evaluate Daratumumab and Ibrutinib to Treat Relapsed / Refractory Chronic Lymphocytic Leukemia Treatment (DIRECT) - Mayo Clinic

    Since this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn are unknown, any of ...

  9. A Study to Evaluate the Safety of Acamprosate for Alcohol Use Disorder - Mayo Clinic

    Although no human trial data is available, animal studies suggest possible teratogenic effects of acamprosate (Merck, 2005). Eligibility last updated 5/17 ...

  10. Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer - Mayo Clinic

    Not pregnant and not nursing, because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus ...